TD Cowen cuts PT on Hims & Hers, citing valuation concerns

Brokerage TD Cowen cuts price target on telehealth company Hims & Hers HIMS.N to $37 from $48, citing valuation concerns

The new PT represents 6.6% upside to stock's last close

Brokerage sees strong growth prospects; says telehealth platforms like HIMS are focused on personalized care, boosting subscriber adoption

Adds co is venturing into at-home testing for more accurate and personalized care

Three of 15 brokerages rate stock "buy" or higher, 10 "hold", two "sell"; median PT is $40, according to data compiled by LSEG

HIMS rose ~34% in 2025